Bone Biologics Corp. (BBLG)
0.5615
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 16:00
0.5615
0.00 (0.00%)
After-Hours: 18:27
Bone Biologics Shareholders Equity (Quarterly) : 3.925M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.925M |
| March 31, 2026 | 4.670M |
| December 31, 2025 | 5.378M |
| September 30, 2025 | 6.016M |
| June 30, 2025 | 6.596M |
| March 31, 2025 | 2.911M |
| December 31, 2024 | 3.484M |
| September 30, 2024 | 3.792M |
| June 30, 2024 | 2.909M |
| March 31, 2024 | 3.675M |
| December 31, 2023 | 2.906M |
| September 30, 2023 | 3.793M |
| June 30, 2023 | 5.693M |
| March 31, 2023 | 2.772M |
| December 31, 2022 | 5.947M |
| September 30, 2022 | 4.402M |
| June 30, 2022 | 5.588M |
| March 31, 2022 | 6.039M |
| December 31, 2021 | 6.576M |
| September 30, 2021 | -15.13M |
| June 30, 2021 | -14.62M |
| March 31, 2021 | -14.12M |
| December 31, 2020 | -13.69M |
| September 30, 2020 | -13.24M |
| June 30, 2020 | -12.84M |
| Date | Value |
|---|---|
| March 31, 2020 | -12.46M |
| December 31, 2019 | -11.87M |
| September 30, 2019 | -11.38M |
| June 30, 2019 | -10.86M |
| March 31, 2019 | -9.972M |
| December 31, 2018 | -8.598M |
| September 30, 2018 | -7.174M |
| June 30, 2018 | -9.456M |
| March 31, 2018 | -8.534M |
| December 31, 2017 | -8.396M |
| September 30, 2017 | -10.90M |
| June 30, 2017 | -10.25M |
| March 31, 2017 | -8.270M |
| December 31, 2016 | -8.364M |
| September 30, 2016 | -7.050M |
| June 30, 2016 | -5.316M |
| March 31, 2016 | -3.012M |
| December 31, 2015 | -5.681M |
| September 30, 2015 | -2.199M |
| June 30, 2015 | -0.8982M |
| March 31, 2015 | |
| December 31, 2014 | -3.698M |
| September 30, 2014 | -4.352M |
| June 30, 2014 | -6.219M |
| January 31, 2014 | -0.0418M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.437M |
| Total Liabilities (Quarterly) | 0.512M |
| Current Ratio | 8.665 |